Table II.
Clinical information for 364 patients in different risk categories.
| High-risk group (n=181) | Low-risk group (n=183) | |||
|---|---|---|---|---|
| Characteristics | n | % | n | % |
| Age | ||||
| <65 | 63 | 34.8 | 68 | 37.2 |
| >65 | 118 | 65.2 | 115 | 62.8 |
| Status | ||||
| Alive | 76 | 42.0 | 123 | 67.2 |
| Dead | 105 | 58.0 | 60 | 32.8 |
| Sex | ||||
| Female | 55 | 30.4 | 40 | 21.9 |
| Male | 126 | 69.6 | 143 | 78.1 |
| Stage | ||||
| Stage I | 1 | 0.6 | 3 | 1.6 |
| Stage II | 32 | 17.7 | 63 | 34.4 |
| Stage III | 79 | 43.6 | 59 | 32.2 |
| Stage IV | 69 | 38.1 | 58 | 31.7 |
| T stage | ||||
| T1 | 1 | 0.6 | 4 | 2.2 |
| T2 | 38 | 21.0 | 72 | 39.3 |
| T3 | 108 | 59.7 | 84 | 45.9 |
| T4 | 34 | 18.8 | 23 | 12.6 |
| M stage | ||||
| M0 | 81 | 44.8 | 97 | 53.0 |
| M1 | 4 | 2.2 | 4 | 2.2 |
| Unknown | 96 | 53.0 | 82 | 44.8 |
| N stage | ||||
| N0 | 108 | 59.7 | 105 | 57.4 |
| N1 | 28 | 15.5 | 15 | 8.2 |
| N2 | 36 | 19.9 | 39 | 21.3 |
| N3 | 3 | 1.7 | 2 | 1.1 |
| Unknown | 6 | 3.3 | 22 | 12.0 |
T stage, tumor stage; N stage, node stage; M stage, metastasis stage.